Summary
- Current Price
- As of today, LYEL price is $14.53, down -0.55% on
- Current Price All-Time High
- LYEL price is currently -96.34% below its historical high of $396.80 set on
- Market Cap
- LYEL current market cap is $356M, up +116.29% over the past 365 days
- Revenue
- LYEL current annual revenue is $36.00K, down -40.98% year-over-year
- Next Earnings
- The next earnings release for LYEL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Lyell Immunopharma, Inc. |
| Ticker | NASDAQ: LYEL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lyell.com |
| Employees | 300 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $14.53 | |
| Price, 1D Change | -0.55% | |
| $356M | ||
| - | ||
| - | ||
| 1.73 | ||
| $36.00K | ||
| Revenue, 1Y Change | -40.98% | |
| -$16.06 | ||
| EPS, 1Y Change | +38.80% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$16.06 | ||
| EPS Estimate | -$6.92 | N/A |
| EPS Est. Change | +56.90% | N/A |
| $36.00K | ||
| Revenue Estimate | $11.88K | N/A |
| Revenue Est. Change | -67.00% | N/A |
| Current Price | $14.53 | |
| Price Target | $41.50 | - |
| Price Tgt. Change | +185.62% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.58 | -$26.23 | -4,423.24% | |
| -$10.53 | -$16.06 | -52.48% | |
| -$6.92 | N/A | +56.90% | |
| -$6.32 | N/A | +60.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $53.00K | $61.00K | +15.09% | |
| $36.20K | $36.00K | -0.55% | |
| $11.88K | N/A | -67.00% | |
| $9,880.00 | N/A | -72.56% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $14.53 | |
| $20.37 | ||
| $13.86 | ||
| $17.39 | ||
| $14.61 | ||
| $0.30 | ||
| 1.73 | ||
| $1.03 | ||
| 50.73 | ||
| 100.38% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $36.00K | ||
| -$16.06 | ||
| -$11.50M | ||
| -31.95% | ||
| -$203.77M | ||
| -566.04% | ||
| -$274.45M | ||
| -762.36% | ||
| -$192.24M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.21 | ||
| 5.28 | ||
| 5.28 | ||
| - | ||
| 2 | ||
| -5.57 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 13.19K | ||
| 1.52 | ||
| -1.06 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $248.20M | ||
| $247.22M | ||
| $340.05M | ||
| $260.94M | ||
| $91.85M | ||
| $49.41M | ||
| $50.99M | ||
| $9.07M | ||
| $2.89M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $274.48M | ||
| $192.27M | ||
| $11.54M | ||
| $0.00 | ||
| $11.54M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$150.02M | ||
| $54.10M | ||
| $50.41M | ||
| $780.00K | ||
| -$150.80M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Stifel | ||
| B. Riley Securities | ||
| Needham | → | |
| Citizens | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | ||
| Citizens |
Analyst sentiment
Institutional ownership
Screeners with LYEL
FAQ
- What is the ticker symbol for Lyell Immunopharma, Inc.?
- The ticker symbol for Lyell Immunopharma, Inc. is NASDAQ:LYEL
- Does Lyell Immunopharma, Inc. pay dividends?
- No, Lyell Immunopharma, Inc. does not pay dividends
- What sector is Lyell Immunopharma, Inc. in?
- Lyell Immunopharma, Inc. is in the Healthcare sector
- What industry is Lyell Immunopharma, Inc. in?
- Lyell Immunopharma, Inc. is in the Biotechnology industry
- What country is Lyell Immunopharma, Inc. based in?
- Lyell Immunopharma, Inc. is headquartered in United States
- When did Lyell Immunopharma, Inc. go public?
- Lyell Immunopharma, Inc. initial public offering (IPO) was on June 17, 2021
- Is Lyell Immunopharma, Inc. in the S&P 500?
- No, Lyell Immunopharma, Inc. is not included in the S&P 500 index
- Is Lyell Immunopharma, Inc. in the NASDAQ 100?
- No, Lyell Immunopharma, Inc. is not included in the NASDAQ 100 index
- Is Lyell Immunopharma, Inc. in the Dow Jones?
- No, Lyell Immunopharma, Inc. is not included in the Dow Jones index
- When was Lyell Immunopharma, Inc. last earnings report?
- Lyell Immunopharma, Inc.'s most recent earnings report was on August 6, 2026
- When does Lyell Immunopharma, Inc. report earnings?
- The next expected earnings date for Lyell Immunopharma, Inc. is November 6, 2026
Data Sources & References
- LYEL Official Website www.lyell.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1806952/000162828026017253/0001628280-26-017253-index.htm
- LYEL Profile on Yahoo Finance finance.yahoo.com/quote/LYEL
- LYEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lyel
